Shengming Jin

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0001-8666-4606

发表论文 43 篇 · 总被引 756 次 · h-index 15

代表论文

• Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments (2022 · Molecular Therapy · 被引 187)
• Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment (2023 · Cell Death and Disease · 被引 37)
• Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study (2023 · Journal of Immunotherapy · 被引 25)
• Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients (2022 · Cancer Immunology Immunotherapy · 被引 23)
• Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity (2023 · Molecular Oncology · 被引 9)
• Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer (2024 · Med · 被引 8)